Results 191 to 200 of about 1,895,427 (309)

Developing Group Model-Building Workshops for Children's Healthy Living Food Systems. [PDF]

Curr Dev Nutr
Hovmand PS, Franck K, Butel J, Galbreath J, Esquivel M, Coleman P, Aflague T, Shallcross L, Ogland-Hand C, Oshiro J, Belyeu-Camacho T, Sikes A, Novotny R.   +12 more
europepmc   +1 more source

Use of the Healthy Living Medicine Platform to Minimize COVID-19 Vaccination: Dispelling This Myth Before It Takes Hold. [PDF]

Am J Med, 2023
Arena R.
europepmc   +1 more source

Masterplanned Communities for Healthy Living [PDF]

, 2012
Bajracharya, Bhishna
core  

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

Effectiveness of "Healthy Living Training Program" on Obese Policemen. [PDF]

Indian J Community Med
Sabale RV, Velhal G, Kabra Y, Nellikkal S.   +3 more
europepmc   +1 more source

"There's a Lot of Like, Contradicting Stuff"-Views on Healthy Living during Pregnancy and Postpartum. [PDF]

Int J Environ Res Public Health, 2022
McNamara JA, Mena NZ, Wright A, Barr ML.
europepmc   +1 more source

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
Keratin 19 (KRT19) is overexpressed in high‐grade serous ovarian cancer with high levels of Kallikrein‐related peptidases (KLK) 4–7 and is associated with poor survival. In vivo analyses demonstrate that elevated KRT19 increases peritoneal tumour burden.
Sophia Bielesch, Isabel Vogel, Sina Nokodian, Johanna Moeller, Antonia Blechschmidt, Vicky Hecht, Vanessa Kuentzel, Katharina Thiedig, Melissa Schwab, Oliver Schilling, Holger Bronger, Marion Kiechle, Viktor Magdolen, Tobias Dreyer   +13 more
wiley   +1 more source

How to collaborate for health throughout the project timeline - a longitudinal study reflecting on implemented strategies in three projects for a healthy living environment. [PDF]

BMC Public Health, 2023
Vooren NJEV, Janssen LMS, Drewes HW, Baan CA, Bongers IMB.   +4 more
europepmc   +1 more source

Dual PI3K/AKT and CDK4/6 inhibition reveals selective sensitivity in an SHH medulloblastoma stem cell model

Molecular Oncology, EarlyView.
Targeted therapy was evaluated in SHH medulloblastoma using neuroepithelial stem cell (NES) and tumor‐derived NES‐like (tNES) models in 2D monolayers and 3D spheroids. PI3K, AKT, and CDK4/6 inhibitors had minimal effects in NES but markedly reduced viability and growth and induced apoptosis in tNES cells, revealing distinct therapeutic vulnerabilities.
Monika Lukoseviciute, Madeleine Birgersson, Paolo Ceriani, Margareta Wilhelm, Ourania N Kostopoulou   +4 more
wiley   +1 more source

Two a Priori Dietary Indices among Young Children in the Children's Healthy Living (CHL) Trial: Validation and Association with Health Outcomes. [PDF]

J Nutr
Shvetsov YB, Yamanaka AB, Dela Cruz R, Butel J, Hammond K, Aflague TF, Coleman P, Shallcross L, Fleming T, Fialkowski MK, Wilkens LR, Novotny R.   +11 more
europepmc   +1 more source